drugset / Trial / NCT03065868
Effect of H. Pylori Eradication on the Fate of H. Pylori-associated Gastric Polyp
RandomizedParallel-groupOpen-labelTreatment
Summary
Evaluation of the effect of H. pylori eradication on regression of H. pylori-related gastric polyp (Ranomized controlled trial) 1. Study design: open labeled RCT 2. Study group H. pylori eradication group (N=17), non-eradication group (N=15) 3. Treatment plan 1. Baseline EGD : 0.3-1cm sized polyp - bx \& CLO test (antrum \& body) ==\> if H. pylori positive and eligible patients, randomization 2. Triple therapy 3. UBT (4week after eradication) 4. Follow-up EGD: gross finding, CLO test 4. Evaluation of polyp regression 1. disappear 2. regression over 50% (size, number) 3. no change or increase (size, number)
Timeline
- Start
- 2015-12-09
- Primary completion
- 2019-04-30
- Completion
- 2019-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amoxaxillin | Unknown | — | — |
| Subject | Clarithromycin | Small molecule | — | — |
| Subject | Lanston | Unknown | — | — |